It is given to patients who have dangerously low blood sugar levels important for cellular metabolism as well as low blood volume. With the release of a new, veterinarylabeled synthetic hydroxyethyl starch product, vetstarch 6% hydroxyethyl starch 0. Lists the various brand names available for medicines containing hydroxyethyl starch. Hydroxyethyl starch in sodium chloride fda prescribing. The concerns grew after three multicentre randomised trials found that administration of hes in patients who had sepsis or were critically ill was associated with a higher risk of kidney injury and bleeding, 1 2 3 and more deaths in. Review of hydroxyethyl starch containing solutions for infusion started. Voluven definition of voluven by medical dictionary. In 20, warnings from both agencies advised against use of hes in critically ill patients, including patients with sepsis, when several large randomized controlled. Hydroxyethyl starch use for patients with postpartum hemorrhage. Americas blood centers, the american red cross, aabb and the american society for apheresis oppose this. Colloidal solution volume expander that contains hydroxyethyl starch 0. Hydroxyethyl starch heshaes, sold under the brand name voluven among others, is a nonionic starch derivative, used as a volume expander in intravenous therapy. Two kind of hydroxyethyl starches are available hexastarch and pentastarch. The food and drug administration fda is announcing a public workshop entitled.
In 45 patients undergoing cardiac surgery, 6% hydroxyethyl starch 2000. Feb 14, 2018 of these 899 subjects, 602 were exposed to voluven i. Butare the available data sufficient to clearly assess the riskbenefit balance for allpatients, and is there enough. Nov 10, 2014 large trials have shown that hydroxyethyl starch increases the risk of death, kidney injury, and bleeding. Using an isothermal desorption controlled airdrying method and. Hydroxyethylstarch solutions for infusion to be suspended. Voluven tetrastarch dosing, indications, interactions. Risks and benefits of hydroxyethyl starch solutions.
Tetrastarch solutions, such as voluven, vetstarch, and tetraspan, are the most recently developed and are considered late generation hes solutions. The type of hydroxyethyl starch present in 6% hydroxyethyl starch 0. Hydroxyethyl starch hescontaining solutions are given by infusion drip into a vein and are used as volume expanders to replace lost fluids in critically ill patients with hypovolaemialow. Review of hydroxyethylstarch containing solutions for. The pendulum has beenswinging away from hydroxyethyl starch hes solutions, in part because of therevelations of fraudulent studies conducted by joachim boldt. Hydroxyethyl starch voluven and volulyte therapeutic. For example, synthetic products like dextran and hydroxyethyl starches and haemoglobin based oxygencarrying solutions along with natural colloids like plasma, whole blood and human serum etc. Sf reports nonfinancial support from baxter healthcare, and financial support from bristolmyers squibb. The influence of two different hydroxyethyl starch solutions. The dilemma of perioperative use of hydroxyethyl starch solutions and the resurgence of interest in using human albumin as an alternative colloid is explored.
Hydroxyethyl starch systemic is used in the treatment of. The mean duration of treatment with hydroxyethyl starch 0. Since the advent of cardiopulmonary bypass, many efforts have been made to avoid the complications related with it. Hydroxyethyl starch definition of hydroxyethyl starch by. Canadian agency for drugs and technologies in health. The impact of hydroxyethyl starches in cardiac surgery. Review of hydroxyethylstarchcontaining solutions for. During clinical development, a total of 899 subjects received the hydroxyethyl starch 0. Adverse effects of hydroxyethyl starch solutions in surgical. Hydroxyethylstarch voluven the use of hydroxyethyl starch hes solutions has been under scrutiny following publication of studies of its use in critically ill patients 1,2,3. Certain characteristic complications of hes, notably renal impairment, hemorrhage and pruritus, have been well documented with all types of hes solutions. In animal as well as in human studies, the use of hes dissolved in a plasmaadapted solution showed beneficial effects on acidbase status compared with conventional hes dissolved in saline. Mar 21, 2017 this article aims to highlight the positions of the food and drug administration and the european medicines agency regarding use and marketing of hydroxyethyl starch hes products, and how these have changed over recent years. The problem stems from the difficulty in detecting the glass transition of hes samples due to the polydispersity of hes and low sensitivity of calorimetric methods.
Pph is associated with considerable morbidity, and is. The hydroxyethyl starch preparations include tetrastarch, hetastarch, and pentastarch. Hydroxyethyl starch hes is a water soluble semisynthetic polysaccharide that is used as a plasma volume expander and cryoprotectant. In order to produce a fully biodegradable amphiphilic polymer, hes was esterified with lauric, palmitic, and stearic acids under mild reaction conditions using dicyclohexyl carbodiimide dcc and dimethylaminopyridine dmap. Hydroxyethyl starches hess have been used as standard solutions for volume replacement therapy for decades. To evaluate the effects of a 6% hydroxyethyl starch 0. Controversies in the use of hydroxyethyl starch solutions. The cmdh has endorsed the recommendation to suspend the marketing authorisations of hydroxyethyl starch hes solutions for infusion across the european union. Synthetic colloids include hydroxyethyl starch hes solutions as well as the less commonly used dextrans or gelatins. Clinicians rely on hes solutions to expand plasma volume in patients with hypovolemia.
The advantageous biological properties of hydroxyethyl starch hes triggered research interest toward the design and synthesis of drug delivery systems ddss based on this polysaccharide. In 20, both the european medicines agency ema 1 and the us food and drug administration fda 2 decided that hydroxyethyl starch hes solutions should no longer be used in critically ill patients, including those with sepsis. Hydroxyethyl starch solutions and patient harm the lancet. Because of general recommendations to limit the dose of dextran and hydroxyethyl starch hes solutions to 20 ml centered dot kg1 centered dot day1, the use of plasma substitutes for large blood replacement requirements is often achieved with the high cost of albumin administration a general dose recommended for hes solutions is questionable.
Second, roberts and colleagues claim that hes was used to treat postpartum haemorrhage in the. The first group comprises the carbohydrates, sugars, starches and so on. Usually, the colloids used in the medicinal field are isosmolar and have the potential to cause allergic reactions in body but clinically these appear to. Colloids contain larger insoluble molecules, such as gelatin. Search results for hydroxyethyl starch at sigmaaldrich. Pdf the glass transition behaviors of hydroxyethyl starch.
Moderate intraoperative use of hydroxyethyl starch. Hydroxyethyl starch can the safety problems be ignored. Hydroxyethyl starch solutions in critically ill or septic patientsupdate. Christiane hartog and colleagues discuss the evidence and call on doctors to avoid using starch formulations concerns about serious side effects. Adverse effects of hydroxyethyl starch solutions in surgical patients. An intravenous solution of hydroxyethyl starch is used to prevent shock following severe blood loss caused by trauma, surgery, or another problem. Convenient reaction schemes, including onestep reactions, led to the synthesis of hes conjugates with selected anticancer molecules or therapeutic proteins. Christiane hartog and colleagues discuss the evidence and call on doctors to avoid using starch formulations. There are 4 fdaapproved hes solutions on the market for this condition. These products are used as plasma volume replacement following acute sudden blood loss, where treatment. Healthcare products regulatory agency to advise the european medicines agency on the continued licensing of intravenous hydroxyethyl starch solutions. The concerns grew after three multicentre randomised trials found that administration of hes in patients who had sepsis or were critically ill was associated with a higher risk of kidney injury and bleeding, 1 2 3 and more deaths in patients who had sepsis, 1 3 when.
Feb 14, 2018 a study with 10% radiolabeled 14 c hydroxyethyl starch 0. Pdf should hydroxyethyl starch solutions be totally banned. Recent evidence from clinical studies and metaanalyses has raised few concerns about the safety of these fluids, especially in certain subpopulations of patients. Hydroxyethyl starch an overview sciencedirect topics. In vivo effect of hydroxyethyl starch solution hes 0. Jones p a et al 2001 effect of hydroxyethyl starch infusion on colloid oncotic pressure in hypoproteinemic horses. The glass transition behaviors of hydroxyethyl starch. Jul 14, 2018 roberts and colleagues1 correspondence in the lancet asking who to support a ban on the use of hydroxyethyl starch hes deserves clarification. Concerns about serious side effects of hydroxyethyl starch hes began to emerge in the 1970s, soon after it was first licensed. They have prolonged half life and expand plasma effectively for 4 hours.
Hydroxyethyl starch solutions for infusion to be suspended cmdh endorses prac recommendation ema357952018 page 23 these products are being suspended in the eu in view of the serious risks that certain patients for example those who are very ill or have blood poisoning are exposed to. Nov 10, 2014 concerns about serious side effects of hydroxyethyl starch hes began to emerge in the 1970s, soon after it was first licensed. Molecular weight and molar substitution have continuously been adapted to minimise adverse effects such as impairment of blood coagulation or renal function. Suspension due to serious risks of kidney injury and death in certain patient populations. In this study, we aimed to compare the effects of 6% hydroxyethyl starch 0. Hydroxyethyl starch is a synthetic colloid volume expander that is used to maintain vascular volume in animals with circulatory shock. Hydroxyethyl starch hes is widely used for fluid resuscitation in icus, but its safety and efficacy have not been established in patients with severe sepsis. We conclude that the four colloids tested, consisting of two gelatinbased fluids, another containing hydroxyethyl starch and another based on albumin, each cause a metabolic acidosis of near identical severity to that caused by saline on ex vivo haemodilution, despite weak acid a. Dec 11, 2014 clinical trials have reported an increased risk of renal dysfunction and mortality in critically ill or septic patients who received hydroxyethyl starch hes compared with crystalloids. Plasma and blood volume expanders medicine libretexts.
Largedose administration of 6% hydroxyethyl starch 2000. Second, roberts and colleagues claim that hes was used to treat postpartum haemorrhage in the woman trial. Find information on hydroxyethyl starch use, treatment, drug class and molecular formula. Fda warns of increased mortality risk with hes solution. In addition to albumin, hydroxyethyl starch has been com pared with crystalloid solutions for resuscitation in critically ill patients. This solution contains dextrose, a form of glucose. Side effects of voluven hydroxyethyl starch in sodium. The purpose of this public workshop is to discuss new information on the risks and benefits of fdaapproved hydroxyethyl starch hes solutions. Top american libraries canadian libraries universal library community texts project gutenberg biodiversity heritage library childrens library.
In addition, data pertaining to the comparative intravascular volume expansion. Roberts and colleagues1 correspondence in the lancet asking who to support a ban on the use of hydroxyethyl starch hes deserves clarification. Adverse effects of hydroxyethyl starch solutions in. Replacement solution with added potassium andor dextrose 3. Mar, 20 hydroxyethyl starch hes is widely used for fluid resuscitation in icus, but its safety and efficacy have not been established in patients with severe sepsis. A study with 10% radiolabeled 14 c hydroxyethyl starch 0. The story starts in december 2009 when the journal anesthesia and analgesia published a study comparing the effect of two bypass pump priming solutions, albumin and hydroxyethyl starch. The complaint from public citizen referenced in this docket requests removal of hydroxyethyl starch hes from the u. The choice of which intravenous solution to prescribe remains a matter ofconsiderable debate in intensive care units around the world. It is a modified branchedchain glucose polymer derived from amylopectin sources such as potatoes, sorghum, or maize. These solutions improve microcirculation and hence improve oxygen delivery to tissues.
Any component of the pump participates in occurrence of these adverse events, one of which is the type of prime solution. The problems of using unbuffered solutions during the perioperative period and comparison between restrictive versus liberal fluid management are discussed in full. The use of hes on critically ill patients is associated with an increased risk of death and kidney problems. These compared hes with crystalloids and demonstrated increased risk of kidney injury requiring dialysis in patients with severe sepsis treated with hes. Another common volume expander includes hydroxyethyl starch heshaes, common trade names. Colloid therapy for critically ill patients todays. We performed the current study to investigate the influence of 2 different hydroxyethyl starch hes solutions, the novel medium molecular weight hes 0. Comparison of hydroxyethyl starch regulatory summaries from. Hydroxyethyl starch hes has come into widespread use for fluid management of acutely ill patients. Crystalloids are aqueous solutions of mineral salts or other watersoluble molecules. Clinical trials have reported an increased risk of renal dysfunction and mortality in critically ill or septic patients who received hydroxyethyl starch hes compared with crystalloids.
Do not use hydroxyethyl starch hes products, including 6% hetastarch in 0. Indeed, the persistence of hes molecules in the body is of serious concernand this issue can no longer be ignored by use of newer starches. Although they differ in their criteria for trial inclusion critically ill vs. Letter to the editor moderate intraoperative use of hydroxyethyl starch solutions is safe pivalizza, evan g. Trends have been movingaway from using hydroxyethyl starch solutions following concerns about safety. The glass transition behaviors of hydroxyethyl starch solutions article pdf available in cell preservation technology 21. Examples of colloids definition, types, examples in. At 5 gkg of body weight per day, administered as a bolus injection, fetal retardations and embryolethal effects were observed in rats and rabbits, respectively. Hydroxyethyl starch in balanced electrolyte solution hextend. Despite the increasing use of hydroxyethyl starch hes as a cryo and lyoprotectant, information about its glass transition behavior is scarce. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Should hydroxyethyl starch solutions be totally banned. The story starts in december 2009 when the journal anesthesia and analgesia published a study comparing the effect of two bypass pump priming solutions, albumin and hydroxyethyl starch colloidal. Do not use hydroxyethyl starch solution in critically ill patients because of the increased risk for death and renal injury, the agency said today. A study with 10% radiolabeled 14c hydroxyethyl starch 0. Hydroxyethyl starch use in horses vetlexicon equis from. Drug delivery systems based on hydroxyethyl starch. Veterinary data from experimental and small clinical trials evaluating the coagulopathic effects of hydroxyethyl starch solutions are described. Hydroxyethyl starch use for patients with postpartum. This openlabel study was designed to investigate the pharmacokinetic and pharmacodynamic profiles of hextend in 21 healthy volunteers. To fulfill this concept, balanced colloids, for example, balanced hydroxyethyl starch hes solutions, are necessary in addition to balanced crystalloids. Tot activity ranging from zero with hydroxyethyl starch to well above that of albumin with succinylated. Concerns over use of hydroxyethyl starch solutions the bmj. Hydroxyethyl starch hes solutions like voluven, hespan or hextend 6% solution are widely used for the treatment of hypovolemia low blood volume when plasma volume expansion is desired.
Equal volume of replacement solution and dextrose 2. Data sources include ibm watson micromedex updated 4 may 2020, cerner multum updated 4 may. Three large, welldesigned studies have shown an increased risk of aki and the need for renal replacement therapy rrt using hydroxyethyl starch myburgh 2012. A volume expander is a type of intravenous therapy that has the function of providing volume for the circulatory system. Large trials have shown that hydroxyethyl starch increases the risk of death, kidney injury, and bleeding. Hydroxyethyl starch hes family has been one of the cornerstones in fluid management for over four decades. Hes is a general term and can be subclassified according to average molecular weight, molar substitution, concentration, c2. Dec 23, 2019 a study with 10% radiolabeled 14 c hydroxyethyl starch 0. Primary postpartum hemorrhage pph is defined as blood loss of e 500 ml within 24 hours after giving birth. Fda warns of higher mortality risk with hydroxyethyl starch. Jones p a et al 1997 oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies. Earlier reports suggested that hydroxyethyl starch 0. Voluven hydroxyethyl starch in sodium chloride injection.